Sort
39,280 grants matching “leukemia”
Inhibition of Bcl-xL by Targeted Degradation
$495,601Guangrong Zheng · University Of Florida · R01 · FY2022 · CA
Inhibition of Bcl-xL by Targeted Degradation
$495,601Guangrong Zheng · University Of Florida · R01 · FY2023 · CA
Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL
$495,457Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
$495,457Christoph Rader · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
A New Murine Model for MPN: Pathololgy and Therapy of NF-E2 Overexpression
$495,301Heike L Pahl · Icahn School Of Medicine At Mount Sinai · P01 · FY2015 · CA
Condensates Biophysics
$495,222Richard W Kriwacki · St. Jude Children'S Research Hospital · P01 · FY2025 · CA
Structure-function studies of single transmembrane helix receptors
$495,192Steven Owen Smith · State University New York Stony Brook · R01 · FY2009 · GM
Toxicity Monitoring on Phase III Trials with Administrative Data
$495,102Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2012 · CA
Role of HOTTIP/beta-catenin-HOXA9/PRMT1 axis in hematopoietic and leukemic stem cells
$495,056Suming Huang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA
Lifecourse determinants and outcomes of epigenetic age acceleration across two generations
$495,020Christopher Kuzawa · Northwestern University · R01 · FY2020 · AG
Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors
$494,843Elizabeth Ann Coleman · Univ Of Arkansas For Med Scis · RC2 · FY2010 · NR
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
$494,712Namita Rout · Tulane University Of Louisiana · R33 · FY2022 · AI
Targeting Alloreactivity for Leukemia Eradication
$494,554Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2007 · CA
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
$494,502Dorothy A Sipkins · Duke University · R01 · FY2024 · CA
Cancer and Leukemia Group B - The Ohio State University
$494,501Clara D Bloomfield · Ohio State University · U10 · FY2009 · CA
ALDH Activation to treat Fanconi Anemia
$494,459Kenneth I. Weinberg · Stanford University · R01 · FY2018 · HL
Steroid resistance of airway ILC2s
$494,421Rafeul Alam · National Jewish Health · R01 · FY2019 · AI
Off-the-Shelf Engineered Cord Blood NK Cells for the Treatment of Hematologic Malignancies.
$494,368Katy Rezvani · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
Early Imaging Detection of CV Injury after Cancer
$494,327William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2014 · CA
GEARBOx - a multisite clinical trial matching tool for children with relapsed or refractory cancer
$494,303Samuel Volchenboum · University Of Chicago · U01 · FY2024 · CA
SBIR Phase II: Device for In-ovo Targeting and Delivery to the Early Chicken Embryo
$494,265Phillip L Rybarczyk · Embrex, Inc. · · FY2005 · TIP
Predictors of Adult Leukemia
$494,244Julie Ann Ross · University Of Minnesota · R01 · FY2008 · CA
MAPPING CHROMOSOMES AND GENES IN RELATION TO LEUKEMIA
$494,225Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA
Mechanistic and translational studies of CBF leukemia
$494,188Paul Liu · National Human Genome Research Institute · ZIA · FY2023 · HG
Chromatin Insulators for Human Gene Therapy
$494,139George Stamatoyannopoulos · University Of Washington · P01 · FY2014 · HL